New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 25, 2014
06:40 EDTSNYSanofi poised to meet or exceed EPS guidance, says Deutsche Bank
Deutsche Bank believes that the price increases on Sanofi's Lantus drug will enable the company to meet or exceed its EPS guidance. The firm thinks the momentum of other parts of the company's business is improving, and it keeps a Buy rating on the shares.
News For SNY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 9, 2014
11:19 EDTSNYSanofi reportedly ready to make acquisitions in animal medicine, Bloomberg says
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use